Behavioral Assessment and Medical (BAM) Core

行为评估和医疗(BAM)核心是相互竞争的TMARC更新的一个新组成部分，它合并了前一个供资期间的临床评估和实验室(CAL)和神经精神病学(NP)核心，以提高资源效率。BAM核心现在由神经医学和实验室单位(NLU)和神经精神病学单位(NPU)组成，将通过向TMARC项目和科学核心提供以下内容来广泛促进中心的目标：1)人类参与者的全面神经医学和神经行为特征，2)样本收集/管理，以及3)关于神经医学、实验室和神经行为数据的分析/解释方面的合作和培训。标准化的神经医学评估将侧重于受艾滋病毒、冰毒和老龄化影响的健康方面，包括参与者的医疗和治疗史、神经功能、艾滋病毒疾病分期和医学共病状况(例如Vacs指数、虚弱程度)。实验室评估将包括混合感染测试、临床实验室分析(例如肝转氨酶、血红蛋白)以及脑脊液和血液中反映艾滋病毒复制、免疫功能和氧化应激的可溶性和细胞生物标记物。生物老化的新措施-细胞衰老(端粒缩短)和线粒体老化(mtDNA损伤)被添加以支持TMARC的衰老主题。NLU还将为TMARC的动物项目提供分析，并为TMARC的细胞衰老试点项目提供支持。NPU将提供全面的神经行为评估，包括神经认知能力、复杂的额叶系统行为(冲动/去抑制、感觉寻求和冷漠)、共病精神状况(情绪、ADHD、ASPD和与物质相关的)，以及关键结果，如艺术坚持、危险行为(不安全的性行为、药物使用、驾驶)、基于成绩的lADL评估、在现实世界功能中的独立性(例如，lADL、就业、健康角色功能)、心理社会功能(社会和情绪功能、生活质量)，以及支持TMARC的试点项目，该项目考察新的虚拟现实任务的效用，以评估由于冰毒造成的神经行为障碍的日常影响，艾滋病毒和老龄化。

The Behavioral Assessment and Medical (BAM) Core is a new component of the competing TMARC renewal, that merges the Clinical Assessment and Laboratory (CAL) and Neuropsychiatric (NP) Cores from the prior funding period to improve resource efficiency. Now comprised of the Neuromedical and Laboratory Unit (NLU) and the Neuropsychiatric Unit (NPU), the BAM Core will extensively contribute to Center objectives by providing to TMARC Projects and Scientific Cores: 1) comprehensive neuromedical and neurobehavioral characterization of human participants, 2) specimen collection/management, and 3) collaboration and training regarding the analyses/interpretation of neuromedical, laboratory, and neurobehavioral data. Standardized neuromedical assessments will focus on aspects of health affected by HIV, METH and aging, including participants' medical and treatment history, neurological functioning, HIV disease staging, and medical comorbidity status (e.g., VACS Index, frailty). Laboratory assessments will include tests for co-infections, clinical lab assays (e.g., hepatic transaminases, hemoglobin), and soluble and cellular biomarkers in cerebrospinal fluid and blood that reflect HIV replication, immune functioning, and oxidative stress. New measures of biologic aging - cell senescence (telomere shortening) and mitochondrial aging (mtDNA injury) are added in support of TMARC's aging theme. The NLU also will provide assays for TMARC's animal projects and support for TMARC's pilot project on cell senescence. The NPU will provide comprehensive neurobehavioral assessments, including neurocognitive abilities, complex frontal systems behaviors (impulsivity/disinhibition, sensation-seeking, and apathy), comorbid psychiatric conditions (mood, ADHD, ASPD, and substance-related), plus key outcomes such as ART adherence, risky behaviors (unsafe sex, drug use, driving), performance-based lADL assessments, independence in real world functioning (e.g., lADLs, employment, health role functioning), psychosocial functioning (social and emotional functioning, quality of life) and support for TMARC's pilot project examining the utility of novel, virtual reality tasks to assess the everyday impact of neurobehavioral impairments due to METH, HIV and aging.